Celastrol confers ferroptosis resistance via AKT/GSK3β signaling in high-fat diet-induced cardiac injury
- 9 March 2023
- journal article
- research article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 200, 36-46
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 41 references indexed in Scilit:
- Celastrol-Induced Suppression of the MiR-21/ERK Signalling Pathway Attenuates Cardiac Fibrosis and DysfunctionCellular Physiology and Biochemistry, 2016
- Natural Functions of PLIN2 Mediating Wnt/LiCl Signaling and Glycogen Synthase Kinase 3 (GSK3)/GSK3 Substrate-Related Effects Are Modulated by LipidMolecular and Cellular Biology, 2016
- β-Arrestin 2 Promotes Hepatocyte Apoptosis by Inhibiting Akt ProteinJournal of Biological Chemistry, 2016
- Treatment of Obesity with CelastrolCell, 2015
- Obesity, inflammation, and the gut microbiotaThe Lancet Diabetes & Endocrinology, 2015
- p38α mitogen-activated kinase mediates cardiomyocyte apoptosis induced by palmitateBiochemical and Biophysical Research Communications, 2014
- Celastrol Attenuates Hypertension-Induced Inflammation and Oxidative Stress in Vascular Smooth Muscle Cells via Induction of Heme Oxygenase-1American Journal of Hypertension, 2010
- Lipotoxicity in the heartCurrent Hypertension Reports, 2005
- Toll-like receptor–mediated cytokine production is differentially regulated by glycogen synthase kinase 3Nature Immunology, 2005
- PI3K/Akt signalling pathway and cancerCancer Treatment Reviews, 2004